Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy + Chemoradiotherapy vs. Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
NCT05062005Phase 3Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2021
- Primary completion
- Aug 2027
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, Cisplatin micelle injection (HA132), fluorouracil, gemcitabine in nasopharyngeal carcinoma (NPC), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Started Sep 2021; status: recruiting.
02
Drugs
docetaxelCisplatin micelle injection (HA132)fluorouracilgemcitabine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT05062005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05062005.